Navigation Links
ERT Unveils Full Range of ePRO Solutions Providing the Power of Choice for Clinical Trial Sponsors
Date:12/16/2010

PHILADELPHIA, Dec. 16, 2010 /PRNewswire/ -- ERT (Nasdaq: ERES), a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries, today announced the launch of its comprehensive suite of electronic patient-reported outcome (ePRO) solutions. As the ePRO market continues to grow, ePRO tools have increasingly become more sophisticated, with their development reflecting the diverse needs of sponsors and facilitating compliance by the patient. ERT now offers a broad range of proven modalities of technology, offering the ability to choose the best ePRO solution to suit the requirements of the trial, ensuring its accuracy and success.

The selection of the ideal ePRO modality is reliant on multiple factors including questionnaire complexity, length, site location, patient population, budget and size of trial. To facilitate this complex selection criteria, ERT offers a diverse range of complementary ePRO tools accepted by regulatory authorities globally for collection of reliable accurate data. ERT solutions include the VIAPhone®, VIAPad®, VIAPen® and VIAWeb®, all of which offer the advantages of simplicity, mobility and immediacy of use over traditional paper based methods.  

ERT's VIAPad solution has the capacity for complex diaries, questionnaires and visual scales, alongside the ability to streamline mid-study changes. The VIAWeb solution enables all patients to use a standard internet browser at home or work to securely log into their study diary or assessment and complete necessary information. This is ideal for patients busy at work, with little time to visit a clinical trial site. The VIAPen is a digital pen that offers the simplicity of paper-based methods with the dual advantage of digital data collection. Completing the suite of solutions offered is the VIAPhone, otherwise known as an Interactive Voice Response device. The VIAPhone enables a patient to use a standard landline telephone or cell phone to feedback information. For people reluctant to embrace more innovative technologies or with reduced physical function, this provides the perfect solution.

John Blakeley, Executive Vice President and Chief Commercial Officer at ERT comments, "At ERT we believe that 'one size does NOT fit all.' We believe that to ensure an accurate and successful clinical trial, vendors must offer technologies that are as diverse and varied as the clinical trials themselves. With this in mind, ERT works to ensure that it offers a comprehensive, unbiased choice of sophisticated solutions."

For further information on ERT and its technology and services please email info@ert.com, call +1 215 972 0420 or visit www.ert.com.

For further press information, please contact Fiona Robinson, The Scott Partnership, 1 Whiteside, Station Road, Holmes Chapel, Cheshire CW4 8AA, United Kingdom. Phone +44 1477 539539, Fax +44 1477 539540, Email ert@scottpr.co.uk

About ERT

Based in Philadelphia, PA, eResearchTechnology, Inc. (www.ert.com) is a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries.  The Company is a market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. It is also a leading provider of centralized respiratory technology and services to evaluate pulmonary function efficacy and safety in clinical development.  Sponsors can further use the Company's solutions to streamline the clinical trials process by automating the collection, analysis, and distribution of ePRO clinical data using multi-mode technology in all phases of clinical development as well as selected medical devices for the clinical trials and healthcare industries.

Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties, which could cause actual results to differ materially from those expressed or implied from such statements.  These risks and uncertainties include, without limitation, the Company's ability to obtain new contracts, variability in size, scope and duration of projects, integration of acquisitions, competitive factors, technological development, market demand, and other factors described in the Company's filings with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.


'/>"/>
SOURCE ERT
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CO-REC Unveils List of Approved Electronic Health Record Products
2. Siemens Unveils Biograph mMR Whole-Body Integrated MR-PET System Capable of Simultaneous Data Acquisition
3. Forte Research Systems Unveils the Allegro™ Research on Demand Cloud-Based Product Line
4. Panasonic Unveils CardioHealth® Station at American Heart Association 2010
5. Panasonic Unveils CardioHealth® Station - First Comprehensive Screening Solution to Detect Heart Disease in Asymptomatic Population
6. Biopharma Company UCB Unveils 40 Deserving 2010 Family Epilepsy Scholarship Recipients
7. Shrink Nanotechnologies Unveils Videos of StemDisc450 Prototype Growing Human Embryonic Stem Cells
8. Cleveland Clinic Unveils Top 10 Medical Innovations for 2011
9. Thomson Reuters Unveils Pharmacy Xpert Solution to Improve Medication Management for Hospital Pharmacists
10. Express Scripts Unveils New Opportunities to Drive Down Healthcare Costs; Presents Five Studies at Academy of Managed Care Pharmacy Conference
11. Inc. Magazine Unveils 29th Annual List of Americas Fastest-Growing Private Companies—the Inc. 500
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Pa. , June 23, 2016 Bracket ... will launch its next generation clinical outcomes platform, Bracket eCOA ... Meeting held on June 26 – 30, 2016 in ... the first electronic Clinical Outcome Assessment product of its kind ... Booth #715. Bracket eCOA 6.0 is a flexible ...
(Date:6/23/2016)... and INDIANAPOLIS , June ... receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship is any ... scholarship winners, announced today online at www.diabetesscholars.org ... type 1 diabetes stand in the way of academic ... supported the Foundation,s scholarship program since 2012, and continues ...
(Date:6/23/2016)... , June 23, 2016 Revolutionary ... Oticon , industry leaders in advanced audiology ... of Oticon Opn ™, the world,s first internet ... possibilities for IoT devices.      (Photo: ... introduces a number of ,world firsts,: , ...
Breaking Medicine Technology:
(Date:6/27/2016)... , ... June 27, 2016 , ... "FCPX editors can ... inside of Final Cut Pro X," said Christina Austin - CEO of Pixel Film ... Final Cut Pro X users can now reveal the media of their ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution is underway. ... transport experience for the millions of people who require these medical transport services ... industry through the use of technology. Now, SmartEMS has put forth an industry-changing ...
(Date:6/26/2016)... ... 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic treatment ... Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. This ... of the world’s leading providers of cereal and other breakfast foods. Its residents often ...
(Date:6/26/2016)... NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and ... to be personalized through a fitness app. The fitness app plans to fix the two ... currently only offer a one size fits all type program , They don’t ...
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
Breaking Medicine News(10 mins):